MyAverix Finance MyAverix Finance

EGX

Memphis Pharmaceuticals (MPCI)

Memphis Pharmaceuticals (MPCI) is listed on EGX. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-03-22

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for MPCI

P/E ratio
18.00

Memphis Pharmaceuticals (MPCI) — FAQ

What is MPCI's P/E ratio?

The price-to-earnings (P/E) ratio for Memphis Pharmaceuticals (MPCI) is 18.00 (data as of 2026-03-22).

Does Memphis Pharmaceuticals pay a dividend?

Dividend yield is not available in the current snapshot for Memphis Pharmaceuticals (MPCI). Check the MyAverix Finance app for the latest dividend data.

What exchange is MPCI listed on?

MPCI is listed on EGX.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play